Power Law company profile

PHAXIAM Therapeutics

Biotech & Life Sciences · Lyon, France · Founded 2004 · IPO 2013 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$15M

Market cap · 2026

Revenue

$34M

Latest reported FY

Investors

5 investors on PHAXIAM Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

1.1K monthly visits
across markets

🇫🇷 France100%

Top 1 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo